Aurinia Pharmaceuticals Inc.
(AUPH - NASDAQ)
16,08 USD
📋 Profilo Aziendale

Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies.

|